Calendar Year: 2020

  1. Baser K, Baser HD, Lopez-Candales A. Obstructive sleep apnea and cardiovascular disease: It is not how much we know but rather how much more we need to learn. Postgrad Med. 2020 Apr 6:1-3. doi: 10.1080/00325481.2020.1750183. [Epub ahead of print] No abstract available. PMID: 32233819
  2. Lopez-Candales A, Mounsey JP. COVID-19: an unprecedented pandemia with a potential arrhythmic undertone. Postgrad Med. 2020 Jun 4:1-3. doi: 10.1080/00325481.2020.1774179. Online ahead of print. PMID: 32449876
  3.  Azzalini L, Tzanis G, Mashayekhi K, Uretsky BF, Ojeda S, Pan M, Rinfret S, Avran A, Alaswad  K, Yamane M, Karmpaliotis D, Brilakis E, Mauro Carlino M, Ybarra F.  Solving challenging situations complications in everyday percutaneous coronary intervention using chronic total occusion techniques.  J Inv Cardiol 2019; 32 (3), E63-E72 Mar 2020. PMID: 32123144
  4. Xenogiannis I, Gkargkoulas F, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Garcia S, Doing AH, Dattilo P, Toma C, Uretsky B, Krestyaninov O, Khelimskii D, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Russo JJ, Hakemi E, Hall AB, Nikolakopoulos I, Vemmou E, Karatasakis A, Danek BA, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Temporal trends in chronic total occlusion percutaneous coronary interventions: insights From the PROGRESS-CTO Registry. J Inv Cardiol 2020; 32(4):153-160. Epub 2020 Mar 20.
  5. Xenogiannis I, Gkargkoulas F, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Garcia S, Doing AH, Dattilo P, Toma C, Uretsky B, Kandzari D, Wyman RM, Tamez H, Jaber WA, Samady H, Sheikh A, Potluri S, Love MP, Elbarouni E, Koutouzis M, Tsiafoutis G, Jefferson BK, Patel T, Megaly M, Hall AB, Nikolakopoulis ID, Krestyaninov O, Khelimskii D, Moses JW,  Parikh M, Kirtane AJ, Ali ZA, Khatri J, Morley P, Dargham BB, Vemmou E, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Retrograde chronic total occlusion percutaneous coronary interventions via saphenous vein grafts. JACC Cardiovasc Interv. 2020 Feb 24;13(4):517-526. doi: 10.1016/j.jcin.2019.10.028.PMID: 32081243.
  6. Uretsky BF, Agarwal SK, Vallurupalli SAl-Hawwas M, Hasan R, Miller K, Hakeem A. Prospective evaluation of the strategy of functionally optimized coronary intervention (FCI).  J Am Heart Assoc 2020 9:e015073. DOI:10.1161/JAHA.119.015073.
  7. Xenogiannis I,  Alaswad K, Krestianinov O,  Khelimskii D, Khatri J, Choi J, Jaffer F, Patel M, Mahmud E, Doing A, Dattilo P, Koutouzis M, Tsiafoutis I, Uretsky B, Jefferson B, Patel T, Jaber W, Samady H, Sheikh A, Yeh R, Tamez H, Elbarouni B, Love N, Rafeh NA, Maalouf A, Jaoudeh  FA, Toma C, Shah A, Chandwaney R, Omer M, Megaly M, Vemmou E, Nikolakopoulos I, Rangan B, Garcia S, Abdullah S, Banerjee S, Burke N, Karmpaliotis D, Brilakis E. Impact of adherence to the hybrid algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention. Circulation 2020;(in press).
  8. Latif F, Uyeda L, Edson R, Bhatt D, Goldman S, Holmes D Jr, Rao S, Shunk K, Aggarwal K, Uretsky B, Bolad I, Ziada K, McFalls E, Irimpen A, Truong H, Kinlay S, Papademetriou V, Velagaleti R, Rangan B, Mavromatis K, Shih M-C, Banerjee S, Brilakis E. Stent-only versus adjunctive balloon angioplasty approach for saphenous vein graft percutaneous coronary intervention: insights from DIVA Trial. Circ Cardiovasc Interv. 2020 Feb;13(2):e008494. Doi: 10.1161/CIRCINTERVENTIONS.119.008494. Epub 2020 Feb 5.PMID: 32019343
  9. Latif F, Uyeda L, Edson R, Bhatt D, Goldman S, Holmes D Jr, Rao S, Shunk K, Aggarwal K, Uretsky B, Bolad I, Ziada K, McFalls E, Irimpen A, Truong H, Kinlay S, Papademetriou V,  Velagaleti R, Rangan B, Mavromatis K, Shih M-C, Banerjee S, Brilakis E. Response to Letter by Azzalini et al Regarding Article, “Stent-only versus adjunctive balloon angioplasty approach for saphenous vein graft percutaneous coronary intervention: insights from DIVA Trial. Circ Cadiovasc Interv. 2020 Apr;13(4):e009174. dENTIONS.120.009174. Epub 2020 Apr 13.PMID: 32279564oi: 10.1161/CIRCINTERV
  10. Goel A, Kattoor AJ, Mehta JL. Thiamine supplementation for acute heart failure patients. (editorial) Longhua Chinese Medicine (in press)
  11. Mathur P, Srivastava S, Xy P, Mehta JL. Artificial intelligence, machine learning and cardiovascular disease. Clinical Medicine Insights: Cardiology
  12. Mehta JL, Calcaterra G, Barilla F, Romeo F. COVID-19 infection and the cardiovascular system. Journal of Cardiovascular Medicine 2020 (in press).
  13. Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Hasan R, Miller K, Hakeem A. Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention. J Am Heart Assoc. 2020 Feb 4;9(3):e015073. doi: 10.1161/JAHA.119.015073. Epub 2020 Jan 30.
  14. Subodh Devabhaktuni; Jonathan Shirazi; John Miller. Mapping and Ablation of Ventricle Arrhythmia in patients of LVAD –Cardiac Electrophysiology Clinics. Volume 11, Issue 4, 689 – 697 https://doi.org/10.1016/j.ccep.2019.07.001
  15. Unique Features of Epicardial Ventricular Arrhythmias/Premature Ventricular Complexes Ablated from Coronary Venous System in Veteran Population- Accepted for publication in Indian  pacing and Electrophysiology journal

Calendar Year: 2019

  1. Gan ZSW, Choi W, Lin FC, Tippett R, Joodi G, Pursell I, Simpson RJ Jr. Factors Underlying Increased Incidence of Sudden Unexpected Death in Rural Counties in North Carolina. J Gen Intern Med. 2019 Jun;34(6):815-817. doi: 10.1007/s11606-018-4771-5. PMID: 30684197
  2. Joshipura K, Muñoz-Torres F, Fernández-Santiago J, Patel RP, Lopez-Candales A. Over-the-counter mouthwash use, nitric oxide and hypertension risk. Blood Press. 2020 Apr;29(2):103-112. doi: 10.1080/08037051.2019.1680270. Epub 2019 Nov 11. PMID: 31709856
  3. Rodríguez-Ruiz C, Puig-Carrión G, Delgado-Nieves A, López-Candales A. Kounis Syndrome: A More Commonly Encountered Cause of Acute Coronary Syndrome. Heart Views. 2019 Jul-Sep;20(3):122-125. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_43_19. PMID:31620259
  4. Hernandez-Suarez DF, Kim Y, Villablanca P, Gupta T, Wiley J, Nieves-Rodriguez BG, Rodriguez-Maldonado J, Feliu Maldonado R, da Luz Sant’Ana I, Sanina C, Cox-Alomar P, Ramakrishna H, Lopez-Candales A, O’Neill WW, Pinto DS, Latib A, Roche-Lima A. Machine Learning Prediction Models for In-Hospital Mortality After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2019 Jul 22;12(14):1328-1338. doi: 10.1016/j.jcin.2019.06.013. PMID:31320027
  5. Hernandez-Suarez DF, Kim Y, López FM, Ramakrishna H, López-Candales A. Qualitative Assessment of Color M-Mode Signals in the Evaluation of Left Ventricular Diastolic Function: A Proof of Concept Study. J Cardiothorac Vasc Anesth. 2019 Oct;33(10):2658-2662. doi: 10.1053/j.jvca.2019.05.047. Epub 2019 Jun 8. PMID:31248799
  6. Hernandez-Suarez DF, Lopez-Menendez F, Roche-Lima A, Lopez-Candales A. Assessment of Mitral Annular Plane Systolic Excursion in Patients With Left Ventricular Diastolic Dysfunction. Cardiol Res. 2019 Apr;10(2):83-88. doi: 10.14740/cr837. Epub 2019 Apr 11.PMID: 31019637 Free PMC article.
  7. Hernandez-Suarez DF, Ranka S, Villablanca P, Yordan-Lopez N, González-Sepúlveda L, Wiley J, Sanina C, Roche-Lima A, Nieves-Rodriguez BG, Thomas S, Cox-Alomar P, Lopez-Candales A, Ramakrishna H. Racial/Ethnic Disparities in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights from the Healthcare Cost and Utilization Project’s National Inpatient Sample. Cardiovasc Revasc Med. 2019 Jul;20(7):546-552. doi: 10.1016/j.carrev.2019.04.005. Epub 2019 Apr 9.PMID: 30987828
  8. Habash FJ, Card P, Madmani ME, Boye B, Paydak H. Supraventricular tachycardia of the sick, a unique entity. Turk Kardiyol Dern Ars. 2019 Dec; 47(8):669-673. doi: 10.5543/tkda.2019.16978. PMID:31802764
  9. Abualsuod A, Paydak H, Pothineni NV. An unusual pacing artifact. Turk Kardiyol Dern Ars. 2019 Oct;47(7):616-618. doi: 10.5543/tkda.2018.52386. PMID:31582675
  10. Kattoor AJ, Pothineni NV, Goel A, Syed M, Syed S, Paydak H, Mehta JL. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis. J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):428-434. doi: 10.1177/1074248419841634. Epub 2019 Apr 29. PMID:31035795
  11. Ayan M, Habash F, Alqam B, Gheith Z, Cross M, Vallurupalli S, Paydak H. A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators. Clin Cardiol. 2019 Feb; 42(2):299-304. doi: 10.1002/clc.23144. Epub 2019 Jan 14. PMID: 30592068
  12. Pothineni NV, Kancharla K, Katoor AJ, Shanta G, Paydak H, Kapa S, Deshmukh A. Coronary artery injury related to catheter ablation of cardiac arrhythmias: A systematic review. J Cardiovasc Electrophysiol. 2019 Jan; 30(1):92-101. doi: 10.1111/jce.13764. Epub 2018 Oct 22. PMID: 30288838
  13. Goel A, Agnihotri K, Ashish K, Subramany S, Paydak H. Novel biomarkers for atrial fibrillation: A recent update. Int J Cardiol. 2019 Feb 15; 277:248. doi: 10.1016/j.ijcard.2018.08.077. Epub 2018 Aug 25. No abstract available. PMID: 30173924
  14. K Agnihotri, S Kadavath, AK Jonnalagadda, H Paydak. Leadless Pacemaker Devices. Accepted for publication in the J Ark Med Soc, in April, 2019.
  15. K Agnihotri, S Kadavath, AK Jonnalagadda, H Paydak. Subcutaneous ICD. Accepted for publication in the J Ark Med Soc, in April, 2019.
  16. Kattoor AJ, Abraham A, Vallurupalli SPaydak H. Senile cardiac amyloidosis presenting as tachycardia induced cardiomyopathy: Case report and literature review. Accepted for publication in J Ark Med Soc, in 2019.
  17. Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW,  Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lebo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Tajti P, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Comparison between traditional and guide-catheter extension reverse controlled antegrade dissection and retrograde tracking: insights from the PROGRESS-CTO Registry. J Invasive Cardiol. 2019 Jan; 31(1):27-34. Epub 2018 Nov 11.
  18. Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke  MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky BF, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Khatri JJ,  Jaber W, Samady H, Jefferson B, Patel T, Abdullah S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. Procedural outcomes of percutaneous coronary interventions for chronic total occlusions via the radial approach: insights from an international chronic total occlusion registry. JACC Cardiovasc Interv. 2019 Feb 25;12(4):346-358. doi: 10.1016/j.jcin.2018.11.019.
  19. Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson BK, Patel T, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali  ZA, Doshi D, Tajti P, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Usefulness of atherectomy in chronic total occlusion interventions (from the PROGRESS-CTO registry). Am J Cardiol. 2019 May 1;123(9):1422-1428. doi: 10.1016/j.amjcard.2019.01.054. Epub 2019  Feb 11.PMID: 30798947
  20. Uretsky BF, Linsky N, Turi ZG.  A man of service.  Catheter Cardiovasc Interv. 2019 May 6. 94(1):27-28. doi: 10.1002/ccd.28309.
  21. Azzalini L, Uretsky B, Brilakis ES, Colombo A, Carlino M. Contrast modulation in chronic total  occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2019 Jan 1;93(1):E24-E29. doi: 10.1002/ccd.27869. Epub 2018 Oct 22
  22. Uretsky BF, Vallurupalli S. Is the digitalis leaf still withering? J Am Coll Cardiol. 2019 Aug 6;74(5):628-630. doi: 10.1016/j.jacc.2019.06.021
  23. Sandoval Y, Peter Tajti P, Karatasakis A, Burke MN, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Krestyaninov O, Khelimskii D, Choi  JW, Doing AH, Toma C, Wyman RM, Uretsky B, Garcia S, Koutouzis M, Holper E, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Kandzari DE, Karacsonyi J, Rangan BV, Thompson C, Banerjee S, Brilakis ES. Frequency and outcomes of ad hoc versus  planned chronic total occlusion percutaneous coronary intervention:  multicenter experience. Epub 2019 January 15.J Inv Cardiology 2019; 31(5):133-139.
  24. Rafeedheen R, Agarwal SK, Meek JC, Uretsky BF. Use of “super-glue” to seal a perforation during chronic total occlusion coronary intervention and the potential to “unglue” it. Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28399.[Epub ahead of print] PMID: 31313466.
  25.  Xenogiannis I, Sandoval Y, Peter Tajti P, Karatasakis A, Burke MN,  Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Krestyaninov O, Khelimskii D, Choi JW, Doing AH, Toma C, Wyman RM, Uretsky B, Garcia S, Koutouzis M, Tsiafoutis I, Holper E, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Kandzari DE, Karacsonyi J, Rangan BV, Thompson C, Banerjee S, Brilakis ES. Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention. Int J Cardiol 2019; Jul 3. pii: S0167-5273(18)37361-3. doi:  10.1016/j.ijcard.2019.06.077. [Epub ahead of print]  PMID: 31301862.
  26. Hakeem A, Ghosh B, Shah K, Agarwal S, Kasula S, Hacioglu Y, Bhatti S, Ahmed Z, Uretsky B. Incremental prognostic value of post intervention Pd/Pa in patients undergoing ischemia-driven percutaneous coronary intervention. JACC CV Intv 2019; 12:2002-2014.
  27. Hakeem A, Uretsky BF. Toward a “more perfect” interventional algorithm:  post-interventional functional assessment using quantitative flow ratio (QFR) JACC CV Intv 2019;12:2076-2078.
  28. Almomani A, Abdel-karim A-R, Uretsky BF.  Evaluating equivocal left main stenosis with fractional flow reserve: not all daughter vessels are created equally. Heart International 2019;13(2):38–40 DOI: https://doi.org/10.17925/HI.2019.13.2.38.
  29. Hasan R, Uretsky BF, Agarwal SK. Prolonged balloon inflation to effect full stent expansion in critical CAD during left ventricular support. JACC: Case Reports December 18, 2019, 1 (5) 844-847; DOI:10.1016/j.jaccas.2019.11.026.
  30. Kadavath S, Siraj A, Selahi N, Moursi M, Uretsky BF. Aortofemoral bypass graft access for Impella placement. JACC: Case Reports December 18, 2019, 1 (5) 751-754; DOI:10.1016/j.jaccas.2019.10.019
  31. Tajti P, Xenogiannis I, Gargoulas F, Karmpaliotis D, Alaswad K, Jaffer FA, Patel MP, Burke MN, Garcia S, Krestyaninov O, Koutouzis M, Jaber W, Brilakis ES, Yeh RW, Tamez H, Mahmud E, Choi JW, Khelimskii D, Khatri JJ, Tsiafoutis I, Doing AH, Dattilo P, Toma C, Uretsky BF, Samady H, Jefferson B, Patel T, Potluri S, Kandzari DE, Wyman RM, Abdullah S, Moses J,  Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Russo JJ, Hakemi E, Rangan B, Ungi I, Banerjee S. Contemporary outcomes of the retrograde approach to chronic total occlusion interventions: insights from an International CTO Registry. EuroIntervention. 2019 Oct 22. pii: EIJ-D-19-00441.doi: 10.4244/EIJ-D-19-00441. [Epub ahead of print].
  32. Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators. Ticagrelor in patients with diabetes and stable coronary disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomized trial. Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140- 6736(19)31887-2. Epub 2019 Sep 1.PMID: 31484629.
  33. Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M,  Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee  and Investigators. Ticagrelor in stable coronary disease and diabetes. N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1.
  34. Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES.  In-Hospital outcomes of chronic total occlusion percutaneous coronary interventions in patients with prior coronary artery bypass surgery. Circ Cardiovasc Interv. 2019 Mar;12(3):e007338. doi: 10.1161/CIRCINTERVENTIONS.118.007338. PMID: 30871357
  35. Xenogiannis I, Gkargkoulas F, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M,  Mahmud E, Choi JW, Burke MN, Garcia S, Doing AH, Dattilo P, Toma C, Uretsky B, Kandzari D, Wyman RM, Tamez H, Jaber WA, Samady H, Sheikh A, Potluri S, Love MP, Elbarouni E,  Koutouzis M, Tsiafoutis G, Jefferson BK, Patel T, Megaly M, Hall AB, Nikolakopoulis ID, Krestyaninov O, Khelimskii D, Moses JW,  Parikh M, Kirtane AJ, Ali ZA, Khatri J, Morley P,  Dargham BB, Vemmou E, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. The impact of peripheral artery disease in chronic total occlusion percutaneous coronary intervention (Insights from PROGRESS-CTO registry). Angiology. 2019 Dec 17:3319719895178. doi:  10.1177/0003319719895178. [Epub ahead of print]
  36.  Xenogiannis I, Choi JW, Khatri J,  Doing AH, Dattilo P, Jaffer FA, Uretsky B, Krestyaninov O, Khelimskii D, Patel M, Mahmud E, Potluri S, Koutouzis M, Tsiafoutis G, Jaber WA, Samady H, Jefferson BK, Patel T, Megaly MS,  Hall AB, Vemmou E, Nikolakopoulis ID, Rangan BV,  Abdullah S, Garcia S, Banerjee S, Burke MN, Brilakis ES. Outcomes of subintimal plaque modification in chronic total occlusion interventions. Cath Cardiovasc Intv PMID: 31797507 DOI: 10.1002/ccd.28614.
  37. Bavineni M, Wassennar TM, Agnihotri K, Ussery DW, Lusher TF, Mehta JL. Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood. European Heart Journal 2019;40:1107-1112.
  38. Kattoor AJ, Pothineni NV, Goel A, Syed M, Syed S, Paydak H, Mehta JL. Prescription patterns and outcomes of patients with atrial fibrillation treated with direct oral anticoagulants and warfarin: A real-world analysis. Journal of Cardiovascular Pharmacology and Therapeutics. 2019 Apr 29: PMID: 31035795
  39. Abdelaziz HK, Saad M, Pothineni NVK, Megaly M, Potluri R, Saleh M, Kon DLC, Roberts DH, Bhatt DL, Aronow HD, Abbott JD, Mehta JL. Aspirin for primary prevention of cardiovascular events. Journal of the American College of Cardiology 2019;73:2915-2929. PMID: 31196447 (with editorial).
  40. Kattoor AJ, Goel A, Mehta JL. LOX-1: regulation, signaling and its role in atherosclerosis. Antioxidants (Basel). 2019 Jul 11;8(7). PMID:31336709
  41. Jain N, Hunt SL, Cui H, Phadnis MA, Mahnen JD, Shireman TI, Dai J, , Mehta JL, Rasu RS. Trends for and clinical factors associated with choice of oral P2Y12 inhibitors for patients on chronic dialysis. Cardiovascular Drugs and Therapy 2019 https://doi.org/10. 1007/s 1055
  42. Mehta JL, Bavenini M. Premature birth, infections, and atherosclerotic cardiovascular disease. European Heart Journal. Jul 19..PMID: 31324911
  43. Rizzacasa, Amati F, Romeo F, Novelli G, Mehta JL. Epigenetic modification in coronary atherosclerosis. Journal of the American College of Cardiology 2019;74:1352-1365. PMID: 31488273
  44. Goel A, Kattoor AJ, Mehta JL. Thiamine therapy for chronic heart failure. Is there any future for this vitamin?” (editorial) American Journal of Clinical Nutrition 2019:110(6):1270-1271. PMID:31536119
  45. Mehta JL. Late repercussions of assisted reproductive technology (ART). European Heart Journal ehz609, https://doi.org/10.1093/eurheartj /ehz609
  46. Saad M, Abdelaziz HK, Mehta JL. Aspirin for primary prevention in the elderly. Aging. 2019 11:6618-6619. PMID: 31492828
  47. Saad M, Salehi N, Ding Z, Mehta JL. Blood pressure target in diabetics: how low is too low? Eur Heart J. 2019 Jul 1;40(25):2044-2046. doi: 10.1093/eurheartj/ehz197. PMID: 31220239
  48. Shijie L, Deng X, Zhang P, Wang X, Fan Y, Zhou S, Mu S, Mehta JL, Ding Z. Blood flow patterns regulate PCSK9 secretion via MyD88 mediated proinflammatory cytokines. Cardiovascular Research (in press), 2019 Oct 8. pii: cvz262. doi: 10.1093/cvr/cvz262. [Epub ahead of print]PMID: 31593224
  49. Ding Z, Pothineni NV, Goel A, Lüscher T, Mehta JL. PCSK9 and inflammation: Role of shear stress, pro-inflammatory cytokines and LOX-1. Cardiovascular Research 2019 Nov 20. pii: cvz313. doi: 10.1093/cvr/cvz313. [Epub ahead of print] PMID: 31746997
  50. Mathur P, Kadavath S, Marsh JD, Mehta JL. Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs. European Heart Journal, , ehz836, https://doi.org/10.1093/eurheartj/ehz836
  51. Kore RA, Henson JC, Hamzah RN, Griffin RJ, Tackett AJ, Ding Z, Mehta JL. Molecular events in MSC exosome mediated cytoprotection in cardiomyocytes. Nature Scientific Reports 2019;9:19276. doi: 10.1038/s41598-019-55694-7. PMID:31848380
  52. Kadavath S, Ayan M, Al-Hawwas M. Dynamic Systolic Compression of the Left Anterior Descending Coronary Artery as the First Clue of Postinfarction Left Ventricular Pseudoaneurysm. Can J Cardiol. 2019 Oct;35(10):1419.e9-1419.e11. doi: 10.1016/j.cjca.2019.06.010. Epub 2019 Jun 20. PMID:31601417

Calendar Year: 2018

  1. Chen S, Joodi G, Devinsky O, Sadaf MI, Pursell IW, Simpson RJ Jr. Under-reporting of sudden unexpected death in epilepsy. Epileptic Disord. 2018 Aug 1;20(4):270-278. doi: 10.1684/epd.2018.0979. PMID: 30078774
  2. Hosadurg N, Bogle BM, Joodi G, Sadaf MI, Pursell I, Mendys PM, Mounsey JP, Simpson RJ Jr. Lipid Profiles in Out-of-Hospital Sudden Unexpected Death. Mayo Clin Proc Innov Qual Outcomes. 2018 Aug 24;2(3):257-266. doi: 10.1016/j.mayocpiqo.2018.06.010. eCollection 2018 Sep. PMID: 30225459

Calendar Year: 2017

  1. Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, UretskyBF, Hakeem A.  Utilizing post-intervention fractional flow reserve to optimize acute results and the relationship to long-term outcomes. JACC Cardiovasc Interv. 2016 May 23;9(10):1022-31. PMID: 27198682
  2. Agarwal SK, Kasula S, Almomani A, Hacioglu Y, Ahmed Z, UretskyBF, Hakeem A. Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization. Am Heart J. 2017 Feb;184:10-16.  PMID: 27892882
  3. Agarwal SK, Kasula S, Edupuganti MM, Raina S, Shailesh F, Almomani A, Payne JJ, Pothineni NV, Uretsky BF, Hakeem A.  Clinical decision-making for the hemodynamic “gray zone (FFR  0.75-0.80) and long-term outcomes.  J Invasive Cardiol. 2017 Apr 15.     pii: JIC2017415-1. [Epub ahead of print]  PMID:  28420802
  4. Agnihotri K, Pothineni NV, Charilaou P, Vaidya VR, Thakkar B, Goyal V, Kadavath S, Patel N, Badheka A, Noseworthy P, Kapa S, Friedman P, Gersh B, Paydak H, Deshmukh A.  Impact of atrial fibrillation on outcomes with motor vehicle accidents. Int J Cardiol. 2018 Jan 1;250:128-132. PMID: 29030143
  5. Agrawal M, Hakeem A, Ahmed Z, Uretsky BF. Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: an optical coherence tomography study. Catheter Cardiovasc Interv. 2017 Aug 1;90(2):225-232. PMID:28805036
  6.  Al-Hawwas MMarmagkiolis KMehta JL The Impact of Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement on Left Ventricular Remodeling. Am J Cardiol. 2017 Oct 1;120(7):1198-1202.
  7. Almomani A, Abualsuod A, Paydak H, Peer W, Maskoun W. Chronic lead malposition diagnosis and management: discussion of two cases and literature review. Clin Case Rep. 2017 Feb 1;5(3):270-276.PMID: 28265389
  8. Ayyadevara S, Balasubramaniam M, Alla R, Mehta JL, Shmookler Reis RJ. Aspirin-mediated acetylation protects against multiple neurodegenerative pathologies by impeding protein aggregation. Antioxid Redox Signal. 2017 May 24. PMID: 28537433
  9. Azzalini L, Carlino M, Brilakis ES, Vo M, Rinfret S, UretskyBF, Karmpaliotis D, Colombo A. Subadventitial techniques for chronic total occlusion percutaneous coronary interventions: the   concept of vessel “architecture”.Catheter Cardiovasc Interv. 2017 Mar 17.doi:10.1002/ccd.27025.  [Epub ahead of print] PMID: 28303648
  10. Blanchard M, Burton MC, Geraci MW, Marsh JD, Madiao MP, Proweller A, Rockey DC, Salata RA, Williams CS, Williams J, Tan W, Zaidi M, Todd RF III. Best practices for physician-scientist training programs: recommendations from the Alliance for Academic Internal Medicine. Submitted 2017
  11. Danek B, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer F, Yeh R, Kandzari D, Patel M, Mahmud WE, Wyman M, Toma C, Uretsky B, Garcia S, Moses J, Kirtane AJ, Ali Z,  Karacsonyi J, Sandoval Y, Rangan B, Khalili H, Banerjee S, Brilakis EM. Treatment of left anterior descending coronary artery chronic total occlusion: insights from a contemporary multicenter registry. Cathet Cardiovasc Intervent 2017 (in press).
  12. Enderlin EA, Khaled KT, Oke L, Madmani M, Paydak H. Management of tachyarrhythmia during pregnancy. Turk Kardiyol Dern Ars. 2017 Mar;45(2):189-196. doi: 10.5543/tkda.2016.78606. PMID: 28424445
  13. Hakeem A, Uretsky BF. Clinical and prognostic value of post-stenting FFR. JACC Cardiovasc Intv 2017 Aug 14;10(15):1596.
  14. Hakeem A, Almomani A, Uretsky BF. Role of fractional flow reserve in the management of patients with acute coronary syndromes. Curr Opin Cardiol. 2017 Nov;32(6):767-775. PMID:28799978
  15. Hatem R, Danek B, Karatasakis A, Karmpaliotis D, Alaswad K,  Yeh R, Patel M, Mahmud E, Wyman M, Toma C, Uretsky B,  Garcia S, Moses J, Kirtane AJ, Ali Z, Tajti P,  Karacsonyi J, Sandoval Y, Rangan B, Khalili H, Banerjee S, Brilakis  EM.  Use of the Gaia guidewires in a contemporary multicenter registry of chronic total occlusion percutaneous coronary intervention. Cathet Cardiovasc  Intervent 2017 (in press).
  16. Karacsonyi J, Parikh M,  Danek B, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer F, Yeh R, Kandzari D, Patel M, Mahmud W, Wyman M, Martinez-Parachini R, Toma C, Imre U, Uretsky B, Kirtane AJ, Ali Z, , Sandoval Y, Rangan B, Khalili H, Thompson C,  Banerjee S, Brilakis EM. Incidence, treatment, and outcomes of coronary perforation during chronic total occlusion percutaneous coronary interventions: insights from a multicenter registry. Cathet  Cardiovasc Intervent 2017 (in press).
  17. Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Doing A,  Toma C,Uretsky B, Choi J, Moses JW, Kirtane A, Parikh M, Ali Z, Lombardi WL, Kandzari  DE, Lembo N, Garcia S, Wyman MR, Martinez-Parachini JR, Karatasakis A, Danek BA, Alame AJ, Resendes E, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. The impact of proximal vessel tortuosity on the outcomes of chronic total occlusion percutaneous coronary intervention: insights from a contemporary multicenter registry. J Invasive Cardiol. 2017 May 15. pii: JIC2017515-1. [Epub ahead of print]   PMID: 28570257
  18. Karam F Ayoub KA, Pothineni NVK, Rutland J, Ding Z, Mehta JL.  Immunity, inflammation, and oxidative stress in heart failure: Emerging molecular targets. Cardiovascular Drugs and Therapy 2017 Sep 27. doi: 10.1007/s10557-017-6752-z. [Epub ahead of print] PMID: 28956198
  19. Karatasakis A, Danek B, Karmpaliotis D, Alaswad K,  Jaffar FA, Yeh R, Patel M, Mahmud E, Kandzari K, Lembo L, Toma C,  Choi JW, Doing A, Wyman RM, Lombardi W, Uretsky BF, Garcia S, Moses J, Parikh M, Karacsonyi J, Rangan B, Banerjee S, Brilakis E.  The impact of age and sex on in-hospital outcomes of chronic total occlusion percutaneous coronary intervention.  J Invasive Cardiol. 2017 Apr;29(4):116-122. Epub 2017 Jan 15.PMID:28089997
  20. Kasula S, Agarwal SK, Hacioglu Y, Pothineni NK, Bhatti S, Ahmed Z, UretskyB, Hakeem A. Clinical and prognostic value of post-stenting fractional flow reserve in acute coronary  Heart. 2016 Dec 15;102(24):1988-1994.  PMID: 27492942
  21. Kattor AJ, Pothineni NG, Palagiri D, Mehta JL. Oxidative stress in atherosclerosis. Current Atherosclerosis Reports. 2017;19(11):42. doi: 10.1007/s11883-017-0678-6. Review. PMID: 28921056
  22. Liu D, Zeng X, Li X, Mehta JL, Wang X. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases. Basic Research in Cardiology (in press).
  23. Lowery, III CL, Elliott C, Cooper A,  Hadden C, Sonon RN, Azadi P, Williams DK, Marsh JD, Woulfe DS, Kilic F. Cigarette Smoking-Associated Alteration in Serotonin/Adrenalin Signaling Pathways of Platelets, J Am Heart Assoc. 2017; 6:e005465.
  24. Marsh JD, Chod R. Recruiting Faculty Leaders at US Medical Schools: A process without improvement? Academic Medicine, 2017, PMID 28471777
  25. Mathur P, Thanendrarajan S, Paydak H, Vallurupalli S, Jambhekar K, Bhatti S, Schinke CD, Davies FE, Mehta JL. Cardiovascular complications of multiple myeloma in the elderly. Expert Rev Cardiovasc Ther. 2017 Nov 27:1-11. PMID: 29164945
  26. Payne J, Lo M, Paydak H, Maskoun W. Near-zero fluoroscopy implantation of dual-chamber pacemaker in pregnancy using electroanatomic mapping. HeartRhythm Case Rep. 2017 Jan 27;3(4):205-209. PMID: 28491803
  27. Pothineni NV, Edupuganti MM, Almomani A, Payne J, Raina S, Fnu S, Abualsuad A, Wong J, Uretsky BF, Hakeem A.  Comparison of the prognostic value of non-ischemic fractional flow reserve using intracoronary versus intravenous adenosine. Eurointervention 2017 Jun 13. EIJ-D-16-00375. doi: 10:4244/ EIJ-D-16-00375.  PMID: 28606887
  28. Pothineni NGK, Karathanasis SK, Ding Z, Arulandu A, Varughese KI, Mehta JL.   LOX-1 in atherosclerosis and myocardial ischemia: Biology, genetics, and modulation. Journal of the American College of Cardiology 2017 2017 Jun 6;69:2759-2768. PMID: 28571642
  29. Pothineni NVK,  Subramany S,  Kuriakose K, Shirazi LF, Romeo F, Shah PK, Mehta JL. Infections, atherosclerosis and coronary heart disease. European Heart Journal. 2017 Jul 12. doi: 10.1093/eurheartj/ehx362. PMID: 29020241
  30. Rochlani Y,  Kattoor AJ, Pothineni NV, Palagiri D, Romeo F, Mehta JL. Balancing primary prevention and statin induced diabetes mellitus. American Journal of Cardiology 2017 Jul 14. pii: S0002-9149(17)31116-5. PMID: 28797470
  31. Rochlani Y, Pothineni NVK, Kovelamudi S, Mehta JL. Metabolic Syndrome – Pathophysiology, management and modulation by natural compounds. Therapeutic Advances in Cardiovascular Diseases 2017 Aug;11(8):215-225. PMID: 28639538
  32. Salata RA, Geraci MW, Rockey DC, Blanchard M, Brown NJ, Cardinal LJ, Garcia M, Madaio MP,  Marsh JD, Todd, III RF. U.S. Physician-Scientist Workforce in the 21st Century: Recommendations to Attract and Sustain the Pipeline. Academic Medicine, October 3, 2017.
  33. Sandoval Y,  Karacsonyi J,  Parikh M,  Danek B, Karatasakis A, Karmpaliotis D, Alaswad K,  Jaffer F, Yeh R, Kandzari D,  Choi JW, Moses J, Parikh M, Patel M, Mahmud W, Wyman M, Martinez-Parachini R, Toma C, Imre U, Uretsky B, Kirtane AJ, Ali Z, , Sandoval Y, Rangan B,  Khalili H, Thompson C,  Banerjee S, Brilakis EM. Frequency and outcomes of Ad Hoc versus planned chronic total occlusion percutaneous coronary intervention: insights from a  multicenter registry.  Cathet Cardiovasc Intervent 2017 (in press).
  34. Shirazi LF, Bissett J, Romeo F, Mehta JL. Role of inflammation in heart failure. Current Atherosclerosis Reports 2017;19: 27. doi:10.1007/s11883-017-0660-3.
  35. Tajti P, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud , Choi JW, Doing AH, Toma C, Uretsky B, Garcia S, Moses JW, Parikh M, Kirtane A, Ali ZA,  Hatem R, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES. Retrograde CTO-PCI of native coronary arteries via left internal mammary grafts: insights from a multicenter US registry. J Invasive Cardiol. 2017 Nov 15. pii: JIC20171115-1. [Epub ahead of  print]  PMID: 29138364.
  36. Uretsky BF, Agrawal M, Ahmed Z, Hakeem A. Association of stent strut malapposition with long-term outcome. Cathet Cardiovasc Intervent 2017; Dec 27. doi: 10.1002/ccd.27459. [Epub ahead of print] No abstract available.  PMID:29280534
  37. Uretsky BF, Agarwal SK, Hakeem A. Letter by Uretsky et al regarding article “Prognostic value of fractional flow reserve measured immediately after drug-eluting stent implantation”. Circ Cardiovasc Interv. 2017Oct;10(10). pii: e005914. PMID:29038226
  38. Ussia GP, Cammalleri V, Mehta JL, Sarkar K, Muscoli S, de Vico P, Ruvolo G, Romeo F. Transcatheter mitral valve replacement with a novel self-expandable prosthesis: single institutional experience procedural outcomes and follow-up. Journal of Cardiovascular Medicine (Hagerstown). 2017;18:415-424.. PMID: 28240641
  39. Vallurupalli S, Shanbhag A, Mehta JL. Controversies in postoperative atrial fibrillation after non-cardiothoracic surgery: clinical and research implications.  Clinical Cardiology. 2017;40:329-332.. PMID: 28272807
  40. Vallurupalli S, Kasula S, Kumar Agarwal S, Pothineni NV, Abualsuod A, Hakeem A, Ahmed Z, Uretsky BF. A novel stent inflation protocol improves long-term outcomes compared with rapid inflation/deflation deployment method. Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26930.
  41. Vallurupalli S, Uretsky BF.  Letter by Vallurupalli and Uretsky regarding article “ optical coherence tomogragraphy to optimize results of percutaneous coronary intervention in non-ST segment acute coronary syndromes: results of the multicenter, randomized DOCTORS study.Circulation. 2017 Feb 28;135(9):e140-e141. 116.025743.  PMID:28242644
  42. Vallurupalli S, Kasula S, Kumar Agarwal S, Pothineni NV, Abualsuod A, Hakeem A, Ahmed Z, Uretsky BF. A novel stent inflation protocol improves long-term outcomes compared with rapid inflation/deflation method.  Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26930. [Epub ahead of print]  PMID: 28112479
  43. Vallurupalli S, Garg A, Carlino M, Hakeem A, Uretsky BF. Full stent expansion of chronic total occlusion lesions requires prolonged inflation. Cardiovasc Revasc Med. 2017 Sep 11. pii: S1553-8389(17)30348-2. PMID:29066341
  44. Vallurupalli S, Uretsky BF. Current approach to coronary stent deployment. Textbook of Catheter-based Cardiovascular Interventions; Knowledge-based approach, 2ndedition, Springer Publishers. 2017.

Calendar Year: 2016

  1. Abdallah AO, Vallurupalli S, Kunthur A. Pazopanib- and bevacizumab-induced reversible heart failure in a patient with metastatic renal cell carcinoma: A case report. J Oncol Pharm Pract. 2016 Jun;22(3):561-5. PubMed PMID: 25956420.
  2. Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes. JACC Cardiovasc Interv. 2016;9(10):1022-31.
  3. Agrawal M, Hakeem A, Ahmed Z, Uretsky BF. Utility of Frequency Domain Optical Coherence Tomographic Evaluation of Angiographically Optimized Stented Lesions. J Invasive Cardiol. 2016;28(3):94-7.
  4. Ayoub K, Nairooz R, Almomani A, Marji M, Paydak H, Maskoun W. Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation: Evidence from Meta-analysis.J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2215-21. PMID: 27289185
  5. Ayyadevara S, Mercanti F, Wang X, Macintosh S, Tackett AJ, Prayaga SVS, Romeo F, Shmookler Reis R, Mehta JL. Age- and hypertension-associated protein aggregates in mouse heart have similar proteomic profiles. Hypertension Hypertension. 2016 May;67(5):1006-13.
  6. Balamurugan A, Delongchamp A, Lucy I, Bates J, Mehta JL. Neighborhood and acute myocardial infarction mortality as related to the driving time to percutaneous coronary intervention capable hospital. Journal of the American Heart Association 2016 J 16;5 pii: e002378. PMID: 26883922
  7. Bhatti S, Hendel RC, Lopez-Mattei J, Schwartz RG, Raff G, Einstein AJ. Frequent MUGA Testing in a Myeloma Patient: A Case-Based Ethics Discussion. J Nucl Cardiol. 2016 Jun 6. [Epub ahead of print]
  8. Bhatti S, Vallurupalli S, Ambach S, Magier A, Watts E, Truong V, Hakeem A, Mazur W.Myocardial strain pattern in patients with cardiac amyloidosis secondary to multiple myeloma: a cardiac MRI feature tracking study. Int J Cardiovasc Imaging. 2016 Oct 14.
  9. Bhatti S, Watts E, Syed F, Vallurupalli S, Pandey T, Jambekar K, Mazur W, Hakeem A. Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2016 May 25.  [Epub ahead of print]
  10. Cariou B, Ding Z, Mehta JL. PCSK9 and atherosclerosis: beyond LDL-cholesterol lowering. (Editorial). Atherosclerosis 2016;253:275-277.
  11. Condamine T, Dominguez1 J, Kossenkov JV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C, Partlova S, Garfall A, Vogel DT, Xu X, Knight SC, Malietzis G, Lee GH, Eruslanov E, Albelda SM, Wang X, Mehta JL, Bewtra M, Rustgi A, Hockstein N, Witt R, Masters G, Nam B, Smirnov B, Sepulveda A, and Gabrilovich DI. Lectin-type oxidized LDL receptor 1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Science Immunology 2017.
  12. Dai Y, Zhang Z, Cao Y, Mehta JL. MiR-590-5p Inhibits Oxidized- LDL Induced angiogenesis by targeting LOX-1. Nature Scientific Reports 2016;5:16740.
  13. Deshmukh A, Pothineni NV, Patel N, Badheka A, Mulpuru SK, Paydak H, Noseworthy PA. Trends in hospitalizations of young patients with atrial fibrillation: A cause for concern? Int J Cardiol. 2016 Jan 15;203:164-5. doi: 10.1016/j.ijcard.2015.10.169. PMID: 26523359
  14. Ding Z, Liu S, Wang X, Mathur P, Dai Y, Theus S, Deng X, Fan Y, Mehta JL. Vascular smooth muscle cell PCSK9 and mtDNA damage cross-talk: Role in apoptosis. Antioxidants and Redox Signaling. 2016 (in press). PMID: 27197615
  15. Hakeem A, Edupuganti MM, Almomani A, Pothineni NV, Payne J, Abualsuod AM, Bhatti S, Ahmed Z, Uretsky BF. Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve. J Am Coll Cardiol. 2016;68(11):1181-91.
  16. Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Grines CL, Marmagkiolis K. Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue. Circulation. 2016;133(13):1272-89.
  17. Iliescu CA, Grines CL, Herrmann J, Yang EH, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas KP, Leesar MA, Marmagkiolis K. SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista).Catheter Cardiovasc Interv. 2016 Jan 12.
  18. Kasula S, Agarwal SK, Hacioglu Y, Pothineni NK, Bhatti S, Ahmed Z, Uretsky B, Hakeem A. Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes. Heart. 2016 Aug 4. pii: heartjnl-2016-309422.
  19. Kattoor AJ, Mehta JL. Alternate day atorvastatin vs. daily atorvastatin in LDL-cholesterol reduction – A meta-analysis. Current Research Cardiology 2016; 3:71-4
  20. Khan R, Al-Hawwas M, Hatem R, Azzalini L, Fortier A, Joliecoeur EM, Tanguay JF, Lavoie-L’Allier P, Ly HQ. Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2016 Nov;88(5):740-747..PMID: 26833916
  21. Klionsky DJ…. Mehta JL….Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2016 Jan 2;12:1-222. PMID: 26799652.
  22. Limaye K, Vallurupalli S, Lee RW. Myasthenia of the Heart. Am J Med. 2016. Jun;129(6):e19-21. doi: 10.1016/j.amjmed.2016.01.020. PubMed PMID: 26841298.
  23. Marsh JD, Chod R. Recruiting Faculty Leaders at US Medical Schools: A process without improvement? Academic Medicine, (in press).
  24. Mathur P, Paydak H, Thanendrarajan S, van Rhee F Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions. Clin Lymphoma Myeloma Leuk. 2016 Feb;16(2):70-5. Review. PMID: 26776085
  25. Mehta JL, Pothineni NVK. Inflammation in heart failure: the Holy Grail? (editorial) In response to: Increasing regulatory T cells with interleukin-2 and interleukin-2 antibody complexes attenuates lung inflammation and heart failure by Wang et al. Hypertension 2016, PMID: 27160195
  26. Pant S, Patel S, Patel N, Deshmukh A, Mehta JL. Caveat Emptor: Antibiotics, endocarditis, and statistical artifacts. Journal of the American College of Cardiology 2016;67:2090-1. PMID:26227896.
  27. Patel NJ, Edla S, Deshmukh A, Nalluri N, Patel N, Agnihotri K, Patel A, Savani C, Patel N, Bhimani R, Thakkar B, Arora S, Asti D, Badheka AO, Parikh V, Mitrani RD, Noseworthy P, Paydak H, Viles-Gonzalez J, Friedman PA, Kowalski M. Gender, Racial, and Health Insurance Differences in the Trend of Implantable Cardioverter-Defibrillator (ICD) Utilization: A United States Experience Over the Last Decade. Clin Cardiol. 2016 Feb;39(2):63-71. PMID: 26799597
  28. Pothineni NV, Shah NS, Rochlani Y, Nairooz R, Raina S, Leesar MA, Uretsky BF, Hakeem A. U.S. Trends in Inpatient Utilization of Fractional Flow Reserve and Percutaneous Coronary Intervention. J Am Coll Cardiol. 2016;67(6):732-3.
  29. Raina S, Lensing SY, Nairooz RS, Pothineni NV, Hakeem A, Bhatti S, Pandey T. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis. JACC Cardiovasc Imaging. 2016 Aug 2016
  30. Rochlani Y, Klair J, Vallurupalli S, Kenchaiah S. Chiari network and aortic valve endocarditis with concurrent pulmonary and systemic embolization. CASE Cardiovascular Imaging Case Reports. 2017. In Press
  31. Rochlani YM, Shah NN, Pothineni NV, Paydak H. Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation. Cardiol Res Pract. 2016;2016:8956020. PM ID: 26966608
  32. Rochlani Y, Pothineni NV, Paydak H. Irregular Wide Complex Tachycardia in a Young Man. J Ark Med Soc. 2016 Feb;112(10):182-3. PMID: 26939470
  33. Rochlani Y, Vallurupalli S, Hakeem A, Bhatti S. Refractory Hypoxemia After Laparoscopic Nissen Fundoplication. Can J Cardiol. 2016 Mar;32(3):395.e1-3. PubMed PMID: 26481081
  34. Romeo F, Mehta JL, Cammalleri V, Sarkar K, Muscoli S, de Vico P, Ruvolo G, Kar S, Ussia GP. Transcatheter mitral valve replacement with a novel self-expandable prosthesis: single institutional experience procedural outcomes and follow up. Journal of cardiovascular Medicine. 2016 in press.
  35. Shah N, Rochlani Y, Pothineni NV, Paydak H. Burden of arrhythmias in patients with multiple myeloma. Int J Cardiol. 2016 Jan 15;203:305-6. PMID: 26520281
  36. Vallurupalli S, Dai Y, Mehta JL. Inflammasomes and atherosclerosis. Cardiovascular Innovations and Applications.2016 ;1(4): 443-450.
  37. Vallurupalli S, Uretsky BF. Deploying bioresorbable vascular scaffolds–tardus, altius, amplius!! Catheter Cardiovasc Interv. 2016 Apr;87(5):847-8. PubMed PMID: 27085025.
  38. Vallurupalli S, Bahia A, Ruiz-Rodriguez E, Ahmed Z, Hakeem A, Uretsky BF. Optimization of stent implantation using a high pressure inflation protocol.Catheter Cardiovasc Interv. 2016 Jan 1;87(1):65-72. PubMed PMID: 26152685
  39. Vallurupalli S. What’s in a Name? Confusing Agitated Saline Contrast with Ultrasound Contrast Agents. Echocardiography. 2016 Jan;33(1):164. PubMed PMID: 26750046
  40. Vallurupalli S, Kasula S, Kumar Agarwal S, Pothineni NV, Abualsuod A, Hakeem A, Ahmed Z, Uretsky BF.A novel stent inflation protocol improves long-term outcomes compared with rapid inflation/deflation deployment method.Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26930
  41. Wang X, Ding Z, Yang F, Dai Y, Chen P, Theus S, Singh S, Budhiraja M, Mehta JL. Modulation of myocardial injury and collagen deposition following ischemia/reperfusion by linagliptin, liraglutide, and both together. Clinical Science 2016;130:1353-1362PMID: 27129181
  42. Wang X, Zhang F , Yang F, Ding Z, Agarwal N , Guo Z, Mehta JL. Effect of linagliptin and liraglutide on glucose- and Ang II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts. Acta Pharmacol Sin. 2016 Aug 8. PMID: 27498780
  43. Xu J, Watts TE, Rutland JJ, Paydak H. Case images: Left apical hemothorax: A rare complication of device implantation. Turk Kardiyol Dern Ars. 2016 Oct;44(7):620. PMID: 27774978

Calendar Year: 2015

  1. Abualsuod A, Rutland JJ, Watts TE, Pandat S, Delongchamp R, Mehta JL. The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction.Cardiovasc Drugs Ther. 2015 Jun;29(3):265-75. doi: 10.1007/s10557-015-6601-x. PMID: 26068409
  2. Abdallah AO, Vallurupalli S, Kunthur A. Pazopanib- and bevacizumab-induced reversible heart failure in a patient with metastatic renal cell carcinoma: A case report. J Oncol Pharm Pract. 2015 May 7. pii: 1078155215585189. [Epub ahead of print] PubMed PMID: 25956420.
  3. Bhatt P, Parikh P, Patel A, Parikh R, Patel A, Mehta JL, Parikh K. Unique Aspects of Coronary Artery Disease in Indian Women. Cardiovasc Drugs Ther. 2015 Aug;29(4):369-76. doi: 10.1007/s10557-015-6594-5.PMID: 26005100
  4. Carlino M, Ruparelia N, Thomas G, Brooks M, Uretsky BF, Brilakis ES, Karmpaliotis D, Hanratty C, Walsh S, Spratt J, Colombo A. Modified contrast microinjection technique to facilitate chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2015 Sep 10. doi: 10.1002/ccd.26242. [Epub ahead of print] PMID: 26356491
  5. Carlino M, Magri CJ, Uretsky BF, Brilakis ES, Walsh S, Spratt JC, Hanratty C, Grantham JA, Rinfret S, Thompson CA, Lombardi WL, Galassi AR, Sianos G, Latib A, Garbo R, Karmpaliotis D, Kandzari DE, Colombo A. Treatment of the chronic total occlusion: a call to action for the interventional community. Catheter Cardiovasc Interv. 2015 Apr;85(5):771-8. doi: 10.1002/ccd.25736. Epub 2014 Nov 22. Review. PMID: 25382239
  6. Carlino M, Figini F, Ruparelia N, Uretsky BF, Godino C, Latib A, Bertoldi L, Brilakis E, Karmpaliotis D, Antoniucci D, Margonato A, Colombo A. Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade. Catheter Cardiovasc Interv. 2015 Aug 26. doi: 10.1002/ccd.26103. [Epub ahead of print] PMID: 26308750
  7. Dai Y, Condorelli G, Mehta JL. Scavenger receptors and non-coding RNAs: relevance in atherogenesis. Cardiovasc Res. 2016 Jan 1;109(1):24-33. doi: 10.1093/cvr/cvv236. Epub 2015 Oct 14. Review.PMID: 26472132
  8. Darouian N, Watts IE, Deshmukh AJ, Wallace T, Paydak H. Right-sided implantation of a biventricular ICD in a patient with persistent left superior vena cava: a challenging engagement. Acta Cardiol. 2015 Feb;70(1):84-5. No abstract available. PMID: 26137809
  9. Ding Z, Liu S, Wang X, Deng X, Fan Y, Shahanawaz J, Shmookler Reis RJ, Varughese KI, Sawamura T, Mehta JL. Cross-talk between LOX-1 and PCSK9 in vascular tissues. Cardiovasc Res. 2015 Sep 1;107(4):556-67. doi: 10.1093/cvr/cvv178. Epub 2015 Jun 19. PMID: 26092101
  10. Ding Z, Liu S, Wang X, Deng X, Fan Y, Sun C, Wang Y, Mehta JL. Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta. Antioxid Redox Signal. 2015 Mar 20;22(9):760-71. doi: 10.1089/ars.2014.6054. Epub 2015 Jan 8. PMID: 25490141 Free PMC Article
  11. Ding Z, Liu S, Wang X, Khaidakov M, Fan Y, Deng X, Xiang D, Mehta JL. Lectin-like oxidized low-density lipoprotein receptor-1 regulates autophagy and Toll-like receptor 4 in the brain of hypertensive mice. J Hypertens. 2015 Mar;33(3):525-33; discussion 533. doi: 10.1097/HJH.0000000000000411. PMID: 25380158
  12. Ding Z, Liu S, Deng X, Fan Y, Wang X, Mehta JL. Hemodynamic shear stress modulates endothelial cell autophagy: Role of LOX-1. Int J Cardiol. 2015 Apr 1;184:86-95. doi: 10.1016/j.ijcard.2015.01.065. Epub 2015 Jan 27. PMID: 25697875
  13. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Developed in collaboration with the American College of Surgeons, American Society of Anesthesiologists, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists, and Society of Vascular Medicine Endorsed by the Society of Hospital Medicine. J Nucl Cardiol. 2015 Feb;22(1):162-215. doi: 10.1007/s12350-014-0025-z. No abstract available. PMID: 25523415
  14. Hakeem A, Uretsky BF. “Just do it!” redux. Catheter Cardiovasc Interv. 2015 May;85(6):977-8. doi: 10.1002/ccd.25936. No abstract available. PMID: 25904224
  15. Hakeem A, Garg A, Bhatti S, Ahmed Z, Uretsky BF. Fractional flow reserve in acute coronary syndrome: a word of caution. EuroIntervention. 2015 Dec 22;11(8):e1-2. doi: 10.4244/EIJV11I8A188. No abstract available. PMID: 26696318
  16. Iliescu C, Grines CL, Herrmann J, Yang EH, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Marmagkiolis K. SCAI expert consensus statement-executive summary evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26375. [Epub ahead of print] PMID: 26700403
  17. Marmagkiolis K, Hakeem A, Cilingiroglu M, Gundogdu B, Iliescu C, Tsitlakidou D, Katramados A. Safety and Efficacy of Stent Retrievers for the Management of Acute Ischemic Stroke: Comprehensive Review and Meta-Analysis. JACC Cardiovasc Interv. 2015 Nov;8(13):1758-65. doi: 10.1016/j.jcin.2015.07.021. PMID: 26476611
  18. Marsh JD, Todd RF. Training and Sustaining Physician Scientists: What is Success? Am. J. Med 2015; 128(4):431-6 PMID: 25554377
  19. Mathur P, Ding Z, Saldeen T, Mehta JL. Tocopherols in the Prevention and Treatment of Atherosclerosis and Related Cardiovascular Disease. Clin Cardiol. 2015 Sep;38(9):570-6. doi: 10.1002/clc.22422. Epub 2015 Aug 14. Review. PMID: 26272221 Free Article
  20. Mathur P, Ostadal B, Romeo F, Mehta JL. Gender-Related Differences in Atherosclerosis. Cardiovasc Drugs Ther. 2015 Aug;29(4):319-27. doi: 10.1007/s10557-015-6596-3. PMID: 26006701
  21. Mehta JL. Women and Heart Disease; A Focus Issue. Cardiovasc Drugs Ther. 2015 Aug;29(4):317-8. doi: 10.1007/s10557-015-6612-7. No abstract available. PMID: 26227896
  22. Nairooz R, Sardar P, Payne J, Aronow WS, Paydak H. Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. Int J Cardiol. 2015;187:426-9. doi: 10.1016/j.ijcard.2015.03.376. Epub 2015 Mar 27. No abstract available. PMID: 25841141
  23. Nairooz R, Sardar P, Pino M, Aronow WS, Sewani A, Mukherjee D, Paydak H, Maskoun W. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation. Int J Cardiol. 2015;187:345-53. doi: 10.1016/j.ijcard.2015.03.323. Epub 2015 Mar 21. PMID: 25839640
  24. Nairooz R, Vallurupalli S, Agrawal M. Letter by Nairooz et al Regarding Article, “Improved Quality of Life After 1 Year With an Invasive Versus a Noninvasive Treatment Strategy in Claudicants: One-Year Results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial”. Circulation. 2015 May 26;131(21):e507. doi: 10.1161/CIRCULATIONAHA.114.013036. PubMed PMID: 26015469.
  25. Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, Hirsch GA, Mehta JL. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015 May 19;65(19):2070-6. doi: 10.1016/j.jacc.2015.03.518.PMID: 25975469
  26. Pant S, Deshmukh A, Mehta JL. Neglecting Enterococci May Lead to a Misinterpretation of the Consequences of Last Changes in Endocarditis Prophylaxis American Heart Association Guidelines. J Am Coll Cardiol. 2015 Nov 10;66(19):2157. doi: 10.1016/j.jacc.2015.08.875. No abstract available.PMID: 26541932
  27. Pant S, Deshmukh A, Badheka A, Mehta JL. Hospitalizations for Endocarditis in the United States. J Am Coll Cardiol. 2015 Oct 20;66(16):1847-8. doi: 10.1016/j.jacc.2015.07.071. No abstract available.PMID: 26483115
    Pant S, Deshmukh A, Mehta JL. Trends in Infective Endocarditis: Incidence, Microbiology, and Valve Replacement in the United States From 2000 to 2011: The Devil Is in the Details. J Am Coll Cardiol. 2015 Sep 8;66(10):1202-3. doi: 10.1016/j.jacc.2015.06.1330. No abstract available. PMID: 26338003
  28. Pothineni NV, Deshmukh A, Padmanabhan D, Kovelamudi S, Patel NJ, Badheka AO, Mulpuru SK, Paydak H, Noseworthy PA. Complication rates of ventricular tachycardia ablation: Comparison of safety outcomes derived from administrative databases and clinical trials. Int J Cardiol. 2015 Dec 15;201:529-31. doi: 10.1016/j.ijcard.2015.08.116. Epub 2015 Aug 13. No abstract available. PMID: 26322600
  29. Pothineni NV, Bahia A, Gobal F, Ahmed Z, Uretsky BF, Hakeem A. “DVT” of the Heart: A “Novel” Treatment for an Old Problem. JACC Cardiovasc Interv. 2015 Aug 24;8(10):e165-6. doi: 10.1016/j.jcin.2015.03.036. No abstract available. PMID: 26315751
  30. Pothineni NV, Rochlani Y, Vallurupalli S, Kovelamudi S, Ahmed Z, Hakeem A, Mehta JL. Comparison of Angiographic Burden of Coronary Artery Disease in Patients With Versus Without Hepatitis C Infection. Am J Cardiol. 2015 Oct 1;116(7):1041-4. doi: 10.1016/j.amjcard.2015.06.035. Epub 2015 Jul 16. PMID: 26256578
  31. Pothineni NV, Mehta JL. Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2015 Sep 3;373 (10):977-8. doi: 10.1056/NEJMc1508386#SA2. No abstract available.PMID: 26332557
  32. Rochlani Y, Pothineni NV, Mehta JL. Metabolic Syndrome: Does it Differ Between Women and Men? Cardiovasc Drugs Ther. 2015 Aug;29(4):329-38. doi: 10.1007/s10557-015-6593-6.PMID: 25994831
  33. Rochlani Y, Vallurupalli S, Hakeem A, Bhatti S. Refractory Hypoxemia After Laparoscopic Nissen Fundoplication. Can J Cardiol. 2015 Jul 3. pii: S0828-282X(15)00506-1. doi: 10.1016/j.cjca.2015.06.027. [Epub ahead of print]PMID: 26481081
  34. Sheikh A, Patel NJ, Nalluri N, Agnihotri K, Spagnola J, Patel A, Asti D, Kanotra R, Khan H, Savani C, Arora S, Patel N, Thakkar B, Patel N, Pau D, Badheka AO, Deshmukh A, Kowalski M, Viles-Gonzalez J, Paydak H. Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future. Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):105-16. doi: 10.1016/j.pcad.2015.07.002. Epub 2015 Jul 8. Review.PMID: 26162957
  35. Thakkar S, Wang X, Khaidakov M, Dai Y, Gokulan K, Mehta JL, Varughese KI. Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein. Sci Rep. 2015 Nov 18;5:16740. doi: 10.1038/srep16740. PMID: 26578342
  36. Uretsky BF, Carlino M. How to improve your “STAR quality”. Catheter Cardiovasc Interv. 2015 Feb 15;85(3):391-2. doi: 10.1002/ccd.25813. No abstract available. PMID: 25684717
  37. Uretsky BF, Mathew J, Ahmed Z, Hakeem A. Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm. Catheter Cardiovasc Interv. 2015 Jun 29. doi: 10.1002/ccd.26034. [Epub ahead of print]PMID: 26119718
  38. Uretsky BF, Mathew J, Ahmed Z, Hakeem A. Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm. Catheter Cardiovasc Interv. 2015 Jun 29. doi: 10.1002/ccd.26034. [Epub ahead of print]PMID: 26119718
  39. Vallurupalli S. What’s in a Name? Confusing Agitated Saline Contrast with Ultrasound Contrast Agents. Echocardiography. 2016 Jan;33(1):164. doi:10.1111/echo.13139. PubMed PMID: 26750046.
  40. ni NV, Deshmukh A, Paydak H. Utility of Routine Exercise Testing to Detect Rate-Related QRS Widening in Patients Without Structural Heart Disease on Class Ic Antiarrhythmic Agents (Flecainide and Propafenone). Am J Cardiol. 2015 Sep 1;116(5):730-2. doi: 10.1016/j.amjcard.2015.05.039. Epub 2015 Jun 3. PMID: 26100588
  41. Vallurupalli S, Uretsky BF. Physician, Shield Thyself! J Invasive Cardiol. 2015 Jul;27(7):317. No abstract available. PMID: 26136278
  42. Vallurupalli S, Bahia A, Ruiz-Rodriguez E, Ahmed Z, Hakeem A, Uretsky BF. Optimization of stent implantation using a high pressure inflation protocol. Catheter Cardiovasc Interv. 2015 Jul 8. doi: 10.1002/ccd.26095. [Epub ahead of print] PubMed PMID: 26152685.
  43. Wang X, Ding Z, Lin J, Guo Z, Mehta JL. LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains. Biochem Biophys Res Commun. 2015 Nov 6;467(1):135-9. doi: 10.1016/j.bbrc.2015.09.100. Epub 2015 Sep 21.PMID: 26393906
  44. Wang W, Lin LL, Guo JM, Cheng YQ, Qian J, Mehta JL, Su DF, Luan P, Liu AJ. Heavy ethanol consumption aggravates the ischemic cerebral injury by inhibiting ALDH2. Int J Stroke. 2015 Dec;10(8):1261-9. doi: 10.1111/ijs.12560. Epub 2015 Jul 14.
  45. Wang X, Guo Z, Ding Z, Khaidakov M, Lin J, Xu Z, Sharma SG, Jiwani S, Mehta JL. Endothelin-1 upregulation mediates aging-related cardiac fibrosis. J Mol Cell Cardiol. 2015 Mar;80:101-9. doi: 10.1016/j.yjmcc.2015.01.001. Epub 2015 Jan 10.